Tocolytics & Uterotonics Flashcards

1
Q

Tocolytics

A

Relax uterus to delay delivery
Inhibit labor via generation or alteration intracellular messengers and/or inhibit synthesis or block action of myometrial stimulant
Administer concomitantly w/ corticosteroids
Onset ≈ 18hrs
Maximum effect at 48hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Magnesium Sulfate

A

Vascular, bronchial, & uterine smooth muscle relaxation
Preeclampsia treatment - relaxes VSMC, ↓SVR/BP, anticonvulsant, ↓fibrin deposition improving circulation to visceral organs
Neonatal SE - hypotonia & respiratory depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Magnesium Sulfate MOA

A

Alter Ca2+ transport & availability for muscle contraction
Complete w/ intracellular Ca2+ → reducing myometrial contractility
Hyperpolarization plasma membrane leads to inhibition myosin light-chain kinase activity
Depress motor endplate sensitivity
Muscle membrane excitability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Magnesium Sulfate Dose

A

Loading dose 4-6g IV over 20-30min
Infusion 1-2g/hr
Therapeutic level 4-9mEq/L
Continue through delivery & 24hrs post-delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Serum Magnesium

A
1.8-3 mg/dL
Tocolytic range 4-8mg/dL
Anticonvulsant 7-9mg/dL
Tendon reflexes abolished 10-12mg/dL
Respiratory depression >12mg/dL
SA/AV blocks (respiratory arrest) 15-20mg/dL
Apnea 18mg/dL
Cardiac arrest 25mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Magnesium Sulfate SE

A
Hypotension 
Sedation
Skeletal muscle weakness
CNS depression
Flushing 
Palpitations
Chest pain
Nausea
Blurred vision
Pulmonary edema
Vascular dilatation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Magnesium Sulfate Overdose

A

Discontinue infusion
Secure airway
IV calcium chloride admin
Diuresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Magnesium Sulfate Anesthetic Implications

A

Hypotension after epidural or general anesthesia administration
Succinylcholine dose not reduced for intubation
Symptomatic hypocalcemia and respiratory compromise have occurred in myotonic dystrophy cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Calcium Channel Blockers

A

Nifedipine commonly used PO or sublingually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ca2+ Channel Blockers MOA

A

Block calcium ions influx through cell membrane
Block calcium release from SR
Inhibit calcium-dependent myosin light chain kinase mediated phosphorylation
Acts on potassium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ca2+ Channel Blockers SE

A
Hypotension exaggerated w/ neuraxial or general anesthesia
Dyspnea
Pulmonary edema
Tachycardia
Headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ca2+ Channel Blockers Anesthetic Implications

A

Expect hypotension w neuraxial or general anesthesia
Potential uterine atony refractory to oxytocin and prostaglandins
- Both act through Ca2+ channels
- Adequate IV access and Methergine to treat uterine atony

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

β2 Agonists

A

β2 receptors result in smooth muscle relaxation
Myometrial contractility inhibition
Increase progesterone production - progesterone causes histologic changes in myometrial cells that limit contractile impulse spread
Ex: Terbutaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

β2 Stimulation

A

↑ blood sugar & insulin levels
K+ redistributed to intracellular compartment lowering levels (as low as 3mEq/L)
Returns to baseline w/in 72hrs
Neonatal hypoglycemia
↑ insulin secretion in response to hyperglycemia
Following delivery glucose load from the mother ceases leading to rebound hypoglycemia
Fetal tachycardia common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

β2 Agonists SE

A
Maternal & fetal tachycardia
Dysrhythmias
Ischemia
Hypotension
Pulmonary edema
Headache
Hyperglycemia
Hypokalemia
↑ plasma renin & vasopressin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

β2 Agonists Anesthetic Implications

A

Delay anesthesia for 60min to allow heart rate to decrease
Avoid drugs that increase heart rate - Ketamine, Atropine, Glycopyrrolate, Thiopental, Pancuronium, Etomidate
Monitor IV administration d/t fluid overload & pulmonary edema risk
Treat hypotension w/ Phenylephrine or Ephedrine

17
Q

Nitric Oxide Donors Inhibitors

A

Nitroglycerine
↑ cyclic guanosine monophosphate (cGMP)
Inactivates myosin light-chain kinase causing smooth muscle relaxation

18
Q

Cyclooxygenase Inhibitors

A

NSAIDs
Converts arachidonic acid to prostaglandin H2
Non-selective: Indomethacin
COX-2 selective: Celecoxib

19
Q

COX Inhibitors Anesthetic Implications

A

Platelet inhibition associated w/ non-selective COX inhibitors
Transient & reversible
Neuroaxial anesthesia not contraindicated
Other maternal side effects minimal and have little concern for anesthesia

20
Q

Tocolytics Anesthetic Implications

A

Neuraxial preferred over general anesthesia
Know baseline BP
Maternal hemorrhage poorly tolerated d/t Magnesium vasodilation
Succinylcholine muscle relaxant choice for rapid sequence induction

21
Q

Utertonics

A

Uterine atony leading postpartum hemorrhage cause

  1. Fundal massage
  2. Administer oxytocin
22
Q

Oxytocin

A

Endogenous hormone produced by posterior pituitary gland - lowers threshold for uterine smooth muscle depolarization
Synthetic oxytocin (Pitocin, Syntocinon) are octapeptides
- Fewer side effects than endogenous
- r/t antidiuretic hormone
Routinely administered after delivery
20-40u/L isotonic IV solution over 15-20min
Used prophylactically to reduce blood loss after delivery
Infusions at low controlled rate are used to induce labor

23
Q

Oxytocin Anesthetic Implications

A

Vasodilation or ↓SVR
Significant hypotension & tachycardia
Avoid IV boluses

24
Q

Ergot Alkaloids

A

2nd line uterine atony treatment
Effective to decrease postpartum blood loss & PPH
Produce tetanic uterine contractions restricting their use during post-delivery period
MOA not clear
α adrenergic agonist effect?
Methergine - synthetic
Ergotrate - semisynthetic

25
Methergine
``` 0.2mg IM Contractions occur w/in minutes Repeat dose in 15-20min Total 0.8mg Ø IV bolus administration → Profound hypertension → Severe N/V → Cerebral hemorrhage ```
26
Methergine Anesthetic Implications
Do NOT use: - Pregnancy-induced or chronic hypertension - Peripheral vascular disease or ischemic heart disease (MI risk) Monitor BP carefully and have vasodilating drugs available N/V occurs in 10-20% women Effect on vomiting center - cerebral vasodilation admin phenylephrine
27
Prostaglandins
80-90% effective in post-partum hemorrhage refractory to oxytocin and ergot alkaloids Second option when Methergine contraindicated
28
Prostaglandins MOA
↑ myometrial Ca2+ levels subsequently ↑ myosin light-chain kinase activity & uterine contraction Reduced need for post-op hysterectomy r/t uterine atony
29
Hemabate
15-Methylprostaglandin F2a (Hemabate) 250mcg IM Repeat 15-30min Total dose 2mg
30
Misoprostol
``` Prostaglandin E1 Analog Reduced blood loss 800-1000mcg Sublingual or buccal Not preferable to other uterotonics for active 3rd stage labor management ```
31
Prostaglandins Anesthetic Implications
Carboprost (Hemabate) in women w/ reactive airway disease → bronchospasm & ventilation-perfusion mismatch & hypoxemia (asthma patients at risk) Misoprostol used in patients w/ reactive airway disease or pulmonary hypertension